• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢肿瘤的 CT 特征:浆液性交界性肿瘤与低级别浆液性癌的关键差异定义。

CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.

机构信息

1 Service de Radiologie, Institut Régional du Cancer de Montpellier, 208 Avenue des Apothicaires, Montpellier, Herault 34298, France.

2 Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.

出版信息

AJR Am J Roentgenol. 2018 Apr;210(4):918-926. doi: 10.2214/AJR.17.18254. Epub 2018 Feb 28.

DOI:10.2214/AJR.17.18254
PMID:29489407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6690180/
Abstract

OBJECTIVE

The objective of our study was to investigate whether the CT features of serous borderline tumors (SBTs) differ from those of low-grade serous carcinomas (LGSCs) and to evaluate if mutation status is associated with distinct CT phenotypes.

MATERIALS AND METHODS

This retrospective study included 59 women, 37 with SBT and 22 with LGSC, who underwent CT before primary surgical resection. Thirty of 59 patients were genetically profiled. Two radiologists (readers 1 and 2) independently and retrospectively reviewed CT examinations for qualitative features and quantified total tumor volumes (TTVs), solid tumor volumes (STVs), and solid proportion of ovarian masses. Univariate and multivariate associations of the CT features with histopathologic diagnoses and mutations were evaluated, and interreader agreement was determined.

RESULTS

At multivariate analysis, the presence of bilateral ovarian masses (p = 0.03), the presence of peritoneal disease (PD) (p = 0.002), and higher STV of ovarian masses (p = 0.002) were associated with LGSC. The presence of nodular PD pattern (p < 0.001 each reader) and the presence of PD calcifications (reader 1, p = 0.02; reader 2, p = 0.003) were associated with invasive peritoneal lesions (i.e., LGSC). The presence of bilateral ovarian masses (p = 0.04 each reader), PD (reader 1, p = 0.01; reader 2, p = 0.004), and higher STV (p = 0.03 for each reader) were associated with the absence of BRAF mutation (i.e., wild type [wt]-BRAF).

CONCLUSION

The CT features of LGSCs were distinct from those of SBTs. The CT manifestations of LGSC and the wt-BRAF phenotype were similar.

摘要

目的

本研究旨在探讨浆液性交界性肿瘤(SBT)的 CT 特征是否与低级别浆液性癌(LGSC)不同,并评估突变状态是否与不同的 CT 表型相关。

材料与方法

本回顾性研究纳入了 59 名女性患者,其中 37 名为 SBT 患者,22 名为 LGSC 患者,均在初次手术切除前接受了 CT 检查。59 例患者中有 30 例进行了基因分析。两名放射科医生(读者 1 和 2)独立且回顾性地对 CT 检查进行定性特征分析,并对卵巢肿块的总肿瘤体积(TTV)、实性肿瘤体积(STV)和实性比例进行定量评估。评估 CT 特征与组织病理学诊断和突变的单变量和多变量关联,并确定读者间的一致性。

结果

多变量分析显示,双侧卵巢肿块(p = 0.03)、腹膜疾病(PD)存在(p = 0.002)和卵巢肿块的 STV 较高(p = 0.002)与 LGSC 相关。存在结节性 PD 模式(每个读者均为 p < 0.001)和 PD 钙化(读者 1,p = 0.02;读者 2,p = 0.003)与侵袭性腹膜病变(即 LGSC)相关。双侧卵巢肿块(每个读者均为 p = 0.04)、PD(读者 1,p = 0.01;读者 2,p = 0.004)和较高的 STV(每个读者均为 p = 0.03)与 BRAF 突变缺失(即 wt-BRAF)相关。

结论

LGSC 的 CT 特征与 SBT 不同。LGSC 的 CT 表现与 wt-BRAF 表型相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b7/6690180/b56a2faf0090/nihms-1042410-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b7/6690180/e65c35ff88d9/nihms-1042410-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b7/6690180/86c07ff02ba3/nihms-1042410-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b7/6690180/b56a2faf0090/nihms-1042410-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b7/6690180/e65c35ff88d9/nihms-1042410-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b7/6690180/86c07ff02ba3/nihms-1042410-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b7/6690180/b56a2faf0090/nihms-1042410-f0003.jpg

相似文献

1
CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.卵巢肿瘤的 CT 特征:浆液性交界性肿瘤与低级别浆液性癌的关键差异定义。
AJR Am J Roentgenol. 2018 Apr;210(4):918-926. doi: 10.2214/AJR.17.18254. Epub 2018 Feb 28.
2
Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.同期发生的卵巢浆液性交界性肿瘤和随后发生的浆液性癌的临床病理和分子特征。
Am J Surg Pathol. 2019 Nov;43(11):1462-1472. doi: 10.1097/PAS.0000000000001325.
3
Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma.NRAS突变在卵巢低级别浆液性癌中是一种罕见的基因事件。
Hum Pathol. 2017 Oct;68:87-91. doi: 10.1016/j.humpath.2017.08.021. Epub 2017 Sep 2.
4
Spectrum of Mutations and Gene Rearrangements in Ovarian Serous Carcinoma.卵巢浆液性癌的突变和基因重排谱。
JCO Precis Oncol. 2021 Sep 16;5. doi: 10.1200/PO.21.00055. eCollection 2021.
5
High Frequency of Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients.日本患者低级别浆液性卵巢癌的高频突变
Diagnostics (Basel). 2019 Dec 27;10(1):13. doi: 10.3390/diagnostics10010013.
6
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.具有交界性分化的浆液性卵巢癌的基因组分类可区分 RAS 通路和 TP53 突变型肿瘤,并确定 NRAS 为致癌驱动基因。
Clin Cancer Res. 2014 Dec 15;20(24):6618-30. doi: 10.1158/1078-0432.CCR-14-1292. Epub 2014 Oct 14.
7
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.低级别浆液性卵巢肿瘤的分子图谱分析鉴定出新型候选驱动基因。
Oncotarget. 2015 Nov 10;6(35):37663-77. doi: 10.18632/oncotarget.5438.
8
Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.在交界性和低级别卵巢癌中测定BRAF V600E(VE1)蛋白表达及第600密码子处BRAF基因突变状态。
Tumour Biol. 2017 May;39(5):1010428317706230. doi: 10.1177/1010428317706230.
9
Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution.卵巢低级别浆液性癌:对在单一机构进行初次手术的33例病例的临床病理研究
Am J Surg Pathol. 2016 May;40(5):627-35. doi: 10.1097/PAS.0000000000000615.
10
Evaluation of MTAP immunohistochemistry loss of expression in ovarian serous borderline tumors as a potential marker for prognosis and progression.评估卵巢浆液性交界性肿瘤中 MTAP 免疫组化表达缺失作为潜在的预后和进展标志物。
Ann Diagn Pathol. 2020 Oct;48:151582. doi: 10.1016/j.anndiagpath.2020.151582. Epub 2020 Aug 12.

引用本文的文献

1
The utility of low-dose pre-operative CT of ovarian tumor with artificial intelligence iterative reconstruction for diagnosing peritoneal invasion, lymph node and hepatic metastasis.低剂量术前卵巢肿瘤CT联合人工智能迭代重建技术在诊断腹膜侵犯、淋巴结及肝转移中的应用价值
Abdom Radiol (NY). 2025 May 13. doi: 10.1007/s00261-025-04977-x.
2
The Convergence of Radiology and Genomics: Advancing Breast Cancer Diagnosis with Radiogenomics.放射学与基因组学的融合:利用放射基因组学推进乳腺癌诊断
Cancers (Basel). 2024 Mar 6;16(5):1076. doi: 10.3390/cancers16051076.
3
Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors.

本文引用的文献

1
CT features of low grade serous carcinoma of the ovary.卵巢低级别浆液性癌的CT特征
Eur J Radiol Open. 2015 Feb 3;2:39-45. doi: 10.1016/j.ejro.2015.01.001. eCollection 2015.
2
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.极端离群值分析可识别低级别浆液性卵巢癌患者中隐匿的丝裂原活化蛋白激酶通路突变。
J Clin Oncol. 2015 Dec 1;33(34):4099-105. doi: 10.1200/JCO.2015.62.4726. Epub 2015 Aug 31.
3
MRI appearances of pure epithelial papillary serous borderline ovarian tumours.
用于早期浆液性交界性卵巢肿瘤和浆液性恶性卵巢肿瘤术前鉴别的影像组学列线图。
Front Oncol. 2024 Jan 15;13:1269589. doi: 10.3389/fonc.2023.1269589. eCollection 2023.
4
Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.磁共振成像在鉴别交界性和恶性浆液性上皮性卵巢肿瘤中的作用。
Abdom Radiol (NY). 2024 Jan;49(1):229-236. doi: 10.1007/s00261-023-04076-9. Epub 2023 Oct 20.
5
Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors.计算机断层扫描在鉴别Ⅰ期交界性卵巢肿瘤与Ⅰ期恶性上皮性卵巢肿瘤中的指标
Diagnostics (Basel). 2023 Jan 28;13(3):480. doi: 10.3390/diagnostics13030480.
6
MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols.基于磁共振成像的放射组学-临床列线图在卵巢上皮性肿瘤预后预测中的应用:不同采集方案的肿瘤体纹理分析。
J Ovarian Res. 2022 Jan 12;15(1):6. doi: 10.1186/s13048-021-00941-7.
7
Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms.机器学习:放射组学在内分泌肿瘤中的应用与最新进展
J Oncol. 2021 Oct 11;2021:8615450. doi: 10.1155/2021/8615450. eCollection 2021.
8
Serous borderline ovarian tumours: an extensive review on MR imaging features.浆液性交界性卵巢肿瘤:磁共振成像特征的广泛综述。
Br J Radiol. 2021 Sep 1;94(1125):20210116. doi: 10.1259/bjr.20210116. Epub 2021 Jul 8.
9
Low-grade serous epithelial ovarian cancer: a comprehensive review and update for radiologists.低级别浆液性上皮性卵巢癌:放射科医生的全面综述与更新
Insights Imaging. 2021 May 11;12(1):60. doi: 10.1186/s13244-021-01004-7.
10
The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology.精准医学中的放射基因组学时代:一种支持肿瘤学诊断、治疗决策和预后评估的新兴方法。
Front Oncol. 2021 Jan 26;10:570465. doi: 10.3389/fonc.2020.570465. eCollection 2020.
纯上皮性浆液性交界性卵巢肿瘤的MRI表现
Clin Radiol. 2015 Apr;70(4):424-32. doi: 10.1016/j.crad.2014.11.005. Epub 2014 Dec 13.
4
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.使用 ADNEX 模型评估术前卵巢癌风险,以区分良性、交界性、早期和晚期侵袭性以及继发性转移性肿瘤:前瞻性多中心诊断研究。
BMJ. 2014 Oct 15;349:g5920. doi: 10.1136/bmj.g5920.
5
MRI appearances of ovarian serous borderline tumor: pathological correlation.卵巢浆液性交界性肿瘤的MRI表现:与病理的相关性
J Magn Reson Imaging. 2014 Jul;40(1):151-6. doi: 10.1002/jmri.24339. Epub 2013 Oct 15.
6
Adnexal masses: development and preliminary validation of an MR imaging scoring system.附件肿块:磁共振成像评分系统的发展与初步验证。
Radiology. 2013 May;267(2):432-43. doi: 10.1148/radiol.13121161. Epub 2013 Mar 6.
7
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.BRAF 突变与低级别浆液性卵巢癌患者的早期疾病和改善的预后相关。
Cancer. 2013 Feb 1;119(3):548-554. doi: 10.1002/cncr.27782. Epub 2012 Aug 28.
8
Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence.交界性卵巢肿瘤:病理诊断困境及侵袭性或致死性复发的危险因素。
Lancet Oncol. 2012 Mar;13(3):e103-15. doi: 10.1016/S1470-2045(11)70288-1.
9
Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.卵巢癌的流行病学和筛查的现代趋势。散发性形式的遗传基础。
Pathol Oncol Res. 2012 Apr;18(2):135-48. doi: 10.1007/s12253-011-9482-8. Epub 2011 Dec 9.
10
Integrated genomic analyses of ovarian carcinoma.卵巢癌的综合基因组分析。
Nature. 2011 Jun 29;474(7353):609-15. doi: 10.1038/nature10166.